Cyclic diamines of formula (I) or their pharmacologically acceptable acid addition salts, and their medical applications are described. These compounds inhibit the action of chemokines such as MIP-1a and/or MCP-1 on target cells, and are useful as a therapeutic drug and/or preventative drug in diseases, such as atherosclerosis, rheumatoid arthritis, and the like where blood monocytes and lymphocytes infiltrate into tissue.
本文描述了式(I)的环状二胺或其药理学上可接受的酸盐以及它们的医学应用。这些化合物抑制
趋化因子如MIP-1a和/或MCP-1对靶细胞的作用,可用作治疗药物和/或预防药物,用于动脉粥样硬化、类风湿性关节炎等疾病,在这些疾病中,血液单核细胞和淋巴细胞浸润组织。